MXCT - MaxCyte GAAP EPS of -$0.11 misses by $0.01 revenue of $8M misses by $0.11M
2023-11-08 16:42:10 ET
- MaxCyte press release ( NASDAQ: MXCT ): Q3 GAAP EPS of -$0.11 misses by $0.01 .
- Revenue of $8M (-24.5% Y/Y) misses by $0.11M .
- Continue to expect to end the year with approximately $200 million in cash, cash equivalents and investments.
- 2023 Total revenue expected to be approximately $34 - 36 million for the year.
For further details see:
MaxCyte GAAP EPS of -$0.11 misses by $0.01, revenue of $8M misses by $0.11M